AGT and cardiac hypertrophy: Accordingly, systolic blood pressure increased by Ang II infusion was not altered by shikonin (Figure 3B), and shikonin reduced cardiac hypertrophy/fibrosis and improved cardiac function with Ang II infusion (Figure 3C–H).